UMIN ID: C000000349
Registered date:10/03/2006
Induction of tumor-specific CTL after mini-transplantation for advanced pancreatic cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | pancreatic cancer |
| Date of first enrollment | 2004/04/01 |
| Target sample size | 9 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Peptide vaccination after mini-transplantation. |
Outcome(s)
| Primary Outcome | Adverse events associated with peptide vaccination |
|---|---|
| Secondary Outcome | Induction of CTL Tumor response |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 65years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | ECOG PS 2-4 |
Related Information
| Primary Sponsor | Department of Hematology & Oncology University of Tokyo Hospital |
|---|---|
| Secondary Sponsor | Department of Gastroenterology University of Tokyo Hospital |
| Source(s) of Monetary Support | Ministry of Health, Labor and Welfare of Japan |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yoshinobu Kanda |
| Address | 7-3-1 Hongo, Bunkyo, Tokyo, Japan Japan |
| Telephone | 03-3815-5411 |
| ycanda-tky@umin.ac.jp | |
| Affiliation | University of Tokyo Hospital Department of Hematology & Oncology |
| scientific contact | |
| Name | Yoshinobu Kanda |
| Address | 7-3-1 Hongo, Bunkyo, Tokyo, Japan Japan |
| Telephone | 03-3815-5411 |
| Affiliation | University of Tokyo Hospital Department of Hematology & Oncology |